Stroke and bleeding risk-associated use of antithrombotic therapies for stroke prevention in atrial fibrillation in routine clinical practice: the BALKAN-AF Survey

被引:0
|
作者
Potpara, T. S. [1 ,2 ]
Dan, G. A. [3 ]
Trendafilova, E. [4 ]
Paparisto, V. [5 ]
Kusljugic, Z. [6 ]
Polovina, M. M. [1 ,2 ]
Musetescu, R. [7 ]
Manola, S. [8 ]
Music, L. J. [9 ]
Lip, G. Y. H. [10 ]
机构
[1] Clin Ctr Serbia, Cardiol Clin, Belgrade, Serbia
[2] Univ Belgrade, Fac Med, Belgrade, Serbia
[3] Univ Bucharest Carol Davila, Bucharest, Romania
[4] Natl Heart Hosp, Sofia, Bulgaria
[5] Univ Hosp Ctr Mother Theresa, Tirana, Albania
[6] Univ Clin Ctr Tuzla, Tuzla, Bosnia & Herceg
[7] Emergency Cty Hosp, Craiova, Romania
[8] Univ Hosp Sestre Milosrdnice, Zagreb, Croatia
[9] Clin Ctr Cardiol, Podgorica, Montenegro
[10] Birmingham City Hosp, Ctr Cardiovasc Sci, Birmingham, W Midlands, England
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
P6208
引用
收藏
页码:1082 / 1083
页数:2
相关论文
共 50 条
  • [21] Secondary stroke prevention in atrial fibrillation: a challenge in the clinical practice
    Christian Tanislav
    Sonja Milde
    Sabine Schwartzkopff
    Nicole Sieweke
    Heidrun Helga Krämer
    Martin Juenemann
    Björn Misselwitz
    Manfred Kaps
    BMC Neurology, 14
  • [22] Effect of pharmacological therapies for stroke prevention on major gastrointestinal bleeding in patients with atrial fibrillation
    Coleman, C. I.
    Sobieraj, D. M.
    Winkler, S.
    Cutting, P.
    Mediouni, M.
    Alikhanov, S.
    Kluger, J.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2012, 66 (01) : 53 - 63
  • [23] Are your atrial fibrillation (AF) patients protected from ischaemic stroke? Clinical characteristics of AF patients eligible for stroke prevention but remaining untreated in UK clinical practice
    Lacoin, L.
    Ridha, E.
    Lefevre, C.
    Donaldson, R.
    Ramagopalan, S.
    Halcox, J.
    EUROPEAN HEART JOURNAL, 2016, 37 : 505 - 506
  • [24] Oral Anticoagulation for Stroke Prevention in Canadian Practice: Stroke Prevention and Rhythm Interventions in Atrial Fibrillation (SPRINT-AF) Registry
    Ha, Andrew C. T.
    Singh, Narendra
    Cox, Jafna L.
    Mancini, G. B. John
    Dorian, Paul
    Fournier, Carl
    Gladstone, David J.
    Lockwood, Evan
    Shuaib, Ashfaq
    Kajil, Mahesh
    Tsigoulis, Michelle
    Gupta, Milan K.
    CANADIAN JOURNAL OF CARDIOLOGY, 2016, 32 (02) : 204 - 210
  • [25] A clinical decision aid for the selection of antithrombotic therapy for the prevention of stroke due to atrial fibrillation
    LaHaye, Stephen Andrew
    Gibbens, Sabra Lynn
    Ball, David Gerald Andrew
    Day, Andrew George
    Olesen, Jonas Bjerring
    Skanes, Allan Cameron
    EUROPEAN HEART JOURNAL, 2012, 33 (17) : 2163 - 2171
  • [26] Doctors' beliefs on the use of antithrombotic therapy in atrial fibrillation: identifying barriers to stroke prevention
    Peterson, GM
    Boom, K
    Jackson, SL
    Vial, JH
    INTERNAL MEDICINE JOURNAL, 2002, 32 (1-2) : 15 - 23
  • [27] Secondary stroke prevention in atrial fibrillation - Lessons from clinical practice
    Evans, A
    Perez, I
    Yu, G
    Kalra, L
    STROKE, 2000, 31 (09) : 2106 - 2111
  • [28] Stroke prevention in atrial fibrillation: the gap between guidelines and clinical practice
    Dan, G-A.
    Dan, A.
    Buzea, A.
    Tanasescu, R.
    Daha, I.
    Stanescu, C.
    EUROPEAN HEART JOURNAL, 2008, 29 : 208 - 208
  • [29] Evaluation of patients' attitudes towards stroke prevention and bleeding risk in atrial fibrillation
    LaHaye, Stephen
    Regpala, Steffi
    Lacombe, Shawn
    Sharma, Mukul
    Gibbens, Sabra
    Ball, David
    Francis, Kori
    THROMBOSIS AND HAEMOSTASIS, 2014, 111 (03) : 465 - 473
  • [30] Dabigatran in atrial fibrillation: balancing secondary stroke prevention against bleeding risk
    Lane, Deirdre A.
    Lip, Gregory Y. H.
    LANCET NEUROLOGY, 2010, 9 (12): : 1140 - 1142